Expression of an LDL receptor allele with two different mutations (E256K and I402T)

• Published in: Molecular pathology Vol. 53; no. 1; pp. 31 - 36
• Main Authors: Ekström, U, Abrahamson, M, Sveger, T, Sun, X-M, Soutar, A K, Nilsson-Ehle, P
• Format: Journal Article
• Language: English
• Published: London BMJ Publishing Group Ltd and Association of Clinical Pathologists 01.02.2000; BMJ; British Medical Journal Publishing Group
• Subjects: Alleles; Animals; Basic Medicine; Biological and medical sciences; Clinical Medicine; Cricetinae; Disorders of blood lipids. Hyperlipoproteinemia; Electrophoresis, Gel, Pulsed-Field; expression; familial hypercholesterolaemia; Farmakologi och toxikologi; Female; Humans; Hyperlipoproteinemia Type II - genetics; Klinisk medicin; low density lipoprotein receptor; Läkemedelskemi; Male; Medical and Health Sciences; Medical sciences; Medicin och hälsovetenskap; Medicinal Chemistry; Medicinska och farmaceutiska grundvetenskaper; Metabolic diseases; Mutagenesis, Site-Directed; Mutation; Pediatrics; Pediatrik; Pharmacology and Toxicology; Polymerase Chain Reaction; Receptors, LDL - genetics; Sequence Analysis, DNA; Human; Family study; Metabolic diseases; Lipids; Hyperlipoproteinemia; Gene expression; Genetic disease; Lipoprotein LDL; Polymerase chain reaction; Hypercholesterolemia; Mutation; Molecular biology; Dyslipemia; Biological receptor
• ISSN: 1366-8714; 1472-4154
• DOI: 10.1136/mp.53.1.31

Aims—To investigate the disease causing event in patients with familial hypercholesterolaemia, carrying two mutations each, E256K in exon 6 and I402T in exon 9, of the gene encoding the low density lipoprotein (LDL) receptor. It was not known whether the mutations were positioned in cis or trans, or if they were each pathogenic separately or only when present together. Methods—Polymerase chain reaction, denaturing gradient gel electrophoresis and sequencing were used to characterise the LDL receptor locus of the patients and family members. The different LDL receptor mutants, constructed in vitro by oligonucleotide directed mutagenesis, were expressed in LDL receptor deficient Chinese hamster ovary (CHOldlA7) cells, to determine the effects of the mutations on LDL receptor function. Results—The two mutations were located on the same allele of the LDL receptor gene. All mutant constructs resulted in the production of a detectable protein in CHO cells. The cells expressing only the I402T mutation, or the combination of I402T and E256K mutations, were seriously affected in mediating uptake and degradation of LDL. Contrary to initial predictions, the cells expressing only the E256K mutation showed essentially the same binding, uptake, and degradation of 125I labelled LDL as cells transfected with normal LDL receptor cDNA. These results suggest that the pathogenic mutation in the patients heterozygous for the E256K/I402T allele is the I402T mutation, and that E256K alone is a rare sequence variation, which does not affect LDL receptor protein function. E256K was not detected either in DNA from a healthy population or in DNA from other hypercholesterolaemic patients studied. Conclusions—Despite the information available on the structure–function relations between the LDL receptor and LDL receptor like proteins, predictions about the disease causing potential of a mutation are not reliable. These results suggest that the I402T mutation is pathogenic and that the substitution of E256K alone is a rare sequence variation, without a detectable phenotype modulating effect.